CATG small interfering RNA used in the pre-diabetic mellitus stage of non-obese diabetic mice improved the function of islet beta cells, reduced islet inflammation and beta cell apoptosis, and lowered the activation level of CD4+T cells, slowing down the progression of diabetes. The gene discussed is CD4; the disease is diabetes mellitus.